Brandywine Global Investment Management LLC lifted its holdings in Humana Inc (NYSE:HUM) by 155.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 29,744 shares of the insurance provider’s stock after purchasing an additional 18,115 shares during the period. Brandywine Global Investment Management LLC’s holdings in Humana were worth $7,379,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of HUM. Nationwide Fund Advisors increased its stake in shares of Humana by 0.4% in the third quarter. Nationwide Fund Advisors now owns 170,587 shares of the insurance provider’s stock worth $41,560,000 after purchasing an additional 758 shares during the period. Raymond James Financial Services Advisors Inc. increased its stake in shares of Humana by 68.0% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 4,724 shares of the insurance provider’s stock worth $1,151,000 after purchasing an additional 1,912 shares during the period. Sei Investments Co. increased its stake in shares of Humana by 97.7% in the third quarter. Sei Investments Co. now owns 52,224 shares of the insurance provider’s stock worth $12,723,000 after purchasing an additional 25,808 shares during the period. New York State Common Retirement Fund increased its stake in shares of Humana by 1.1% in the third quarter. New York State Common Retirement Fund now owns 379,800 shares of the insurance provider’s stock worth $92,531,000 after purchasing an additional 4,000 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of Humana by 613.6% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 26,340 shares of the insurance provider’s stock worth $6,417,000 after purchasing an additional 22,649 shares during the period. Institutional investors and hedge funds own 97.85% of the company’s stock.
In other news, insider M Todoroff Christopher sold 16,389 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $273.37, for a total value of $4,480,260.93. Following the sale, the insider now directly owns 13,447 shares in the company, valued at approximately $3,676,006.39. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Cynthia H. Zipperle sold 1,196 shares of the company’s stock in a transaction that occurred on Friday, March 9th. The shares were sold at an average price of $273.33, for a total value of $326,902.68. Following the completion of the sale, the senior vice president now owns 7,771 shares in the company, valued at $2,124,047.43. The disclosure for this sale can be found here. Over the last quarter, insiders sold 41,775 shares of company stock worth $11,169,845. Corporate insiders own 0.60% of the company’s stock.
Humana Inc (NYSE HUM) opened at $271.09 on Friday. Humana Inc has a 12 month low of $203.48 and a 12 month high of $293.35. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.85 and a current ratio of 1.85. The stock has a market capitalization of $37,240.00, a PE ratio of 15.39, a P/E/G ratio of 1.46 and a beta of 0.95.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The company had revenue of $13.19 billion for the quarter, compared to analyst estimates of $13.14 billion. During the same period in the prior year, the company posted $2.34 EPS. The company’s revenue was up 2.4% compared to the same quarter last year. equities analysts anticipate that Humana Inc will post 13.81 EPS for the current fiscal year.
Humana announced that its board has authorized a stock repurchase plan on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to purchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be paid a $0.50 dividend. This is a positive change from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.74%. The ex-dividend date is Wednesday, March 28th. Humana’s dividend payout ratio is currently 9.09%.
TRADEMARK VIOLATION WARNING: This article was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://stocknewstimes.com/2018/03/16/brandywine-global-investment-management-llc-has-7-38-million-holdings-in-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.